Golimumab: A Novel Anti-Tumor Necrosis Factor

Biologics in Therapy
doi 10.1007/s13554-013-0012-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Infliximab (Anti–Tumor Necrosis Factor Α Antibody)

Archives of Dermatology
2001English

Selective Improvement of Tumor Necrosis Factor Capture in a Cytokine Hemoadsorption Device Using Immobilized Anti-Tumor Necrosis Factor

Journal of Biomedical Materials Research - Part B Applied Biomaterials
Biomedical EngineeringBiomaterials
2010English

Tumor Necrosis Factor

2004English

CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

TRAF5, a Novel Tumor Necrosis Factor Receptor-Associated Factor Family Protein, Mediates CD40 Signaling.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Vasculoprotective Effects of Anti-Tumor Necrosis Factor-Α Treatment in Aging

American Journal of Pathology
Forensic MedicinePathology
2007English

Dermatomyositis Induced by Anti–Tumor Necrosis Factor in a Patient With Juvenile Idiopathic Arthritis

JAMA Dermatology
DermatologyMedicine
2013English

Reactivation of Hepatitis B Virus Following Anti-Tumor Necrosis Factor-Α Therapy

Soonchunhyang Medical Science
2013English

Preparation of Agarose-Glucan for Anti-Tumor Necrosis Factor Protein Drug Delivery

VNU Journal of Science: Natural Sciences and Technology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy